Status:
COMPLETED
Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1
Lead Sponsor:
University of California, Los Angeles
Conditions:
Opioid-Related Disorders
Eligibility:
All Genders
15-99 years
Phase:
PHASE3
Brief Summary
The purpose of this protocol is to to compare the clinical utility of two dosage tapering regimens in Buprenorphine/Naloxone stabilized subjects for opiate detoxification.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Females are not pregnant or lactating
- Subjects meet DSM-IV criteria for opiate dependence, are medically and psychiatrically stable, and do not have a current history of benzodiazepine dependence abuse, dependence, or treatment
Exclusion
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
End Date :
May 1 2005
Estimated Enrollment :
516 Patients enrolled
Trial Details
Trial ID
NCT00078117
Start Date
June 1 2003
End Date
May 1 2005
Last Update
January 12 2017
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Addiction Research & Treatment Services (ARTS)
Denver, Colorado, United States, 80204
2
Denver Health & Hospitals Authority
Denver, Colorado, United States, 80204
3
Hartford Dispensary
Hartford, Connecticut, United States, 06120
4
Connecticut Counseling Centers
Waterbury, Connecticut, United States, 06705